ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01694849
Recruitment Status : Completed
First Posted : September 27, 2012
Last Update Posted : January 14, 2016
Sponsor:
Collaborators:
Naturalpha
Premier Research Group plc
Information provided by (Responsible Party):
Genfit